```xml <problem> Current methods for monitoring biomarkers require invasive procedures or lab-based equipment, limiting the frequency and convenience of testing. This makes it difficult for individuals to track real-time changes in their health status and optimize training or treatment protocols. Existing molecular monitoring technology has stagnated, leaving a gap in readily available data on chemical exposures affecting health and well-being. </problem> <solution> DIA develops portable and wearable electrochemical sensors that enable non-invasive, real-time monitoring of biomarkers through saliva or sweat. These sensors measure hormones, electrolytes, and inflammatory markers, transmitting the data securely to a smartphone application. The system provides individuals with personalized insights into their health, allowing for timely adjustments to training, diet, or other interventions. DIA's technology aims to expand the Internet of Things to include real-time measurements of endogenous and exogenous chemicals, empowering individuals to better protect their health. The company offers both wearable sensors for continuous monitoring and bench-top analyzers requiring less than 1 mL of saliva for instantaneous measurements. </solution> <features> - Electrochemical sensors for measuring biomarkers in saliva and sweat - Real-time data transmission to a smartphone application - Non-invasive sampling for convenient and frequent testing - Wearable and bench-top analyzer options - Measures hormones, electrolytes, and inflammatory markers - Secure data transmission to protect user privacy - Daily test strip for easy sample collection - Results viewable in the DIA app within 5 minutes </features> <target_audience> The primary target audience includes individuals, high-performance operators, and athletes seeking to optimize their health and performance through real-time biomarker monitoring. </target_audience> ```
Funding
$2.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current methods for monitoring biomarkers require invasive procedures or lab-based equipment, limiting the frequency and convenience of testing. This makes it difficult for individuals to track real-time changes in their health status and optimize training or treatment protocols. Existing molecular monitoring technology has stagnated, leaving a gap in readily available data on chemical exposures affecting health and well-being.
Solution
DIA develops portable and wearable electrochemical sensors that enable non-invasive, real-time monitoring of biomarkers through saliva or sweat. These sensors measure hormones, electrolytes, and inflammatory markers, transmitting the data securely to a smartphone application. The system provides individuals with personalized insights into their health, allowing for timely adjustments to training, diet, or other interventions. DIA's technology aims to expand the Internet of Things to include real-time measurements of endogenous and exogenous chemicals, empowering individuals to better protect their health. The company offers both wearable sensors for continuous monitoring and bench-top analyzers requiring less than 1 mL of saliva for instantaneous measurements.
Target Audience
The primary target audience includes individuals, high-performance operators, and athletes seeking to optimize their health and performance through real-time biomarker monitoring.
Features
- Electrochemical sensors for measuring biomarkers in saliva and sweat
- Real-time data transmission to a smartphone application
- Non-invasive sampling for convenient and frequent testing
- Wearable and bench-top analyzer options
- Measures hormones, electrolytes, and inflammatory markers
- Secure data transmission to protect user privacy
- Daily test strip for easy sample collection
- Results viewable in the DIA app within 5 minutes